논문 검색
-
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.
[BACKGROUND] Bruton tyrosine kinase inhibitors (BTKis) are therapeutic agents for relapsed/refractory chronic lymphocytic leukemia (R/R CLL). Previous indirect treatment comparisons are limited in simultaneously comparing multiple intervent…
FULLTEXT: BI-RADS classification randomized -
The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.
[BACKGROUND] The treatment strategy for intestinal non-Hodgkin lymphoma (NHL) and the role of surgery warrant reevaluation. [METHODS] This study analyzed clinical data from a cohort of 12,047 patients diagnosed with intestinal NHL, extract…
FULLTEXT: BI-RADS classification randomized -
A Randomized Trial Evaluating Intraoperative Ischemic Preconditioning of Parathyroid Glands During Total Thyroidectomy: A Signal for Earlier Parathyroid Function Recovery.
[BACKGROUND] Ischemic preconditioning of parathyroid glands (IPCP) is biologically plausible but clinical evidence is limited. In this single-center randomized trial (ChiCTR2000039788), we compared IPCP versus control during total thyroidec…
FULLTEXT: BI-RADS classification randomized -
Comparison of the effects of exercise-based interventions on cardiometabolic health and fatigue in men with prostate cancer receiving androgen deprivation therapy: A network meta-analysis.
[OBJECTIVE] To compare the effects of exercise-based interventions on cardiometabolic health and fatigue in men with prostate cancer receiving androgen deprivation therapy (ADT). [METHODS] A comprehensive search for Randomized controlled s…
FULLTEXT: BI-RADS classification randomized -
Impact of stromal maturity and proportion on prognosis and immune landscape in colorectal cancer.
[BACKGROUND] Tumour microenvironment and cancer cells have constant interaction affecting cancer progression. Tumour-stroma ratio (TSR) in the tumour centre and desmoplastic reaction (DR) classification at the invasive margin are prognostic…
FULLTEXT: BI-RADS classification randomized -
Survival and morbidity in elderly patients treated with cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a population-based study.
[OBJECTIVE] Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has improved outcomes in colorectal cancer (CRC) patients with peritoneal metastases (PM), yet evidence regarding perioperative risk and long-term …
FULLTEXT: BI-RADS classification randomized -
Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluation.
[AIM] Inadequate adherence to colorectal cancer screening reduces individual and population level health benefits. Blood-based tests offer a new modality that may help patients overcome barriers, but there are concerns about the impact of p…
FULLTEXT: BI-RADS classification randomized -
Frailty profiles and symptomatic radiation pneumonitis in patients with lung cancer undergoing radiotherapy: A latent class analysis.
[OBJECTIVE] This study aimed to identify distinct frailty subtypes and their influencing factors, and to further explore the relationship between these frailty characteristics and the occurrence of symptomatic radiation pneumonitis (SRP) in…
FULLTEXT: BI-RADS classification randomized -
Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial.
[OBJECTIVE] This study aims to determine the impact of PROM with a personalized follow-up program on the evaluation of quality of life and self-management for patients after lung cancer resection. [METHODS] Given a formal power calculation…
FULLTEXT: BI-RADS classification randomized -
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison.
[OBJECTIVES] Real-world evidence (RWE) is increasingly used in health technology assessment (HTA) to address uncertainties surrounding the generalizability of randomized clinical trial (RCT) data. Pembrolizumab plus platinum-based chemother…
FULLTEXT: BI-RADS classification randomized -
Text-based prediction of ımmunohistochemical biomarkers in breast cancer using a generative large language model: a retrospective study.
[PURPOSE] Immunohistochemical (IHC) biomarkers such as estrogen receptor (ER), progesterone receptor (PR), HER2, and Ki-67 are essential for the classification and treatment of breast cancer. While radiomics-based models have demonstrated p…
FULLTEXT: BI-RADS classification randomized -
Managing psychological distress in women with breast cancer: A systematic review of intervention trends in the past decade.
[OBJECTIVE] The rising incidence and survival rates of breast cancer have increased the number of breast cancer survivors (BCSs) experiencing psychological distress that often overlaps with anxiety, depression, and fear of recurrence. Many …
FULLTEXT: BI-RADS classification randomized -
A data fusion deep learning approach for accurate organelle-based classification of cancer cells.
[PURPOSE] Microscopy-based cancer cell classification traditionally relies on cell-based morphological features, while subcellular organelle organization remains underutilized. Existing machine learning methods often require manual preproce…
FULLTEXT: BI-RADS classification randomized -
Systematic meta-analysis of the toxicities and side effects of the targeted drug lenvatinib.
[BACKGROUND] Lenvatinib, an effective targeted drug for various cancers, has clinical medication safety concerns due to its toxicities and side effects. [OBJECTIVE] This study evaluated lenvatinib-induced any adverse events (any AEs) and n…
FULLTEXT: BI-RADS classification randomized -
Robotic-assisted versus standard laparoscopic surgery for colorectal cancer in obese patients: a systematic review and meta-analysis.
Colorectal cancer represents a major global health concern and obesity adds complicates its surgical management. This meta-analysis aimed to evaluate the comparative effectiveness and safety of robotic-assisted surgery and standard laparosc…
FULLTEXT: BI-RADS classification randomized -
Research on tissue-resident macrophages in the field of cancer research: a bibliometric analysis from 2004 to 2025.
In the tumor microenvironment, tissue-resident macrophages (TRMs) promote malignant tumor progression, yet their tissue-specific heterogeneity and complex functions bring research challenges. This study analyzes the research status and tren…
FULLTEXT: BI-RADS classification randomized -
Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis.
[BACKGROUND] Although single-agent chemotherapy is the most common approach for treating platinum-resistant or refractory ovarian cancer (PROC), there is growing evidence that combining molecular targeted agents with chemotherapy is benefic…
FULLTEXT: BI-RADS classification randomized -
Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis for matched related donor hematopoietic stem cell transplantation in acute leukemia: a systematic review and meta-analysis.
Although allogeneic hematopoietic stem cell transplantation (HSCT) offers curative potential for acute leukemia, graft-versus-host disease (GVHD) remains a major obstacle to optimal clinical outcomes. Evidence for post-transplant cyclophosp…
FULLTEXT: BI-RADS classification randomized -
Relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis.
[BACKGROUND] Menopausal hormone therapy (MHT) is widely prescribed for alleviating menopausal symptoms. Prior studies have mainly focused on individual hormone therapy formulations. This meta-analysis comprehensively synthesized evidence ac…
FULLTEXT: BI-RADS classification randomized -
Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis.
[BACKGROUND] Elotuzumab, an anti-SLAMF7 monoclonal antibody for multiple myeloma (MM), lacks a comprehensive safety profile from meta-analysis. [METHODS] We systematically searched PubMed, Web of Science, EMBASE and CENTRAL through Februar…
FULLTEXT: BI-RADS classification randomized